Clinical Report: Correction on Qingzhu Granule and Gouty Arthritis
Background
Gouty arthritis is a prevalent inflammatory disorder characterized by the deposition of monosodium urate crystals, leading to acute inflammation and recurrent episodes. The condition affects millions, particularly older adults, and is associated with significant comorbidities.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
Correction acknowledges equal contribution from authors Yulin Qi, Wenwen Li, and Qing Wang.
Qingzhu granule alleviates acute gouty arthritis through HIF-1a-mediated glycolytic metabolic reprogramming in M1 macrophages.
Gout is characterized by the activation of the NLRP3 inflammasome–IL-1β pathway.
Immunometabolism provides insights into the complexities of gouty arthritis beyond crystal deposition.
The prevalence of gout increases with age, particularly in men.
Clinical Implications
The correction of authorship highlights the importance of accurate attribution in research.
